Guardian Pharmacy Services, Inc. (GRDN) Financial Ratio Screen

NYSE Healthcare United States USD 2347M
INSUFFICIENT / NOT IMPLEMENTED*
Automated financial screen · activity assessed separately
Guardian Pharmacy Services, Inc. (GRDN) needs additional financial data before the automated screen can be completed. One or more financial fields are missing; this is not a negative screening result.

Track GRDN screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

GRDN financial screening at a glance

INSUFFICIENT / NOT IMPLEMENTED*Financial ratios shown separately from business review — not a fatwa
Debt ratio
9.0%
Pass vs 30%
Cash ratio
15.9%
Pass vs 30%
Receivables + cash
40.5%
Fail vs 30%
Impermissible income
N/A
Not available vs 5%

Calculation date: 2026-08-31. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleMore financial data neededNo negative conclusion follows from missing data
FTSE/Yasaar-styleMore financial data neededNo negative conclusion follows from missing data
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2025Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Medical Care Facilities) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 9.0%
/ 30%
15.9%
/ 30%
40.5%
/ 30%
N/A INSUFFICIENT / NOT IMPLEMENTED*
FTSE 9.0%
/ 33%
15.9%
/ 33%
40.5%
/ 50%
N/A INSUFFICIENT / NOT IMPLEMENTED*

Financial Highlights

P/E Ratio
35.6
Forward: 25.9
EPS
$1.04
P/B Ratio
10.6
EV/EBITDA
21.1
EV: $2.3B
Revenue
$1.4B
Growth: 2.2%
Current Ratio
1.7

Profitability

Gross Margin 21.6%
Operating Margin 3.5%
Net Margin 4.5%
Return on Equity (ROE) 30.4%
Return on Assets (ROA) 13.4%

Cash Flow & Balance Sheet

Operating Cash Flow$100M
Free Cash Flow$81M
Total Debt$37M
Debt-to-Equity15.2
Current Ratio1.7
Total Assets$413M

Price & Trading

Last Close$37.33
50-Day MA$39.95
200-Day MA$35.55
Avg Volume394K
52-Week Range
$23.14
$47.02

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-08-31 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About Guardian Pharmacy Services, Inc. (GRDN)

CEO
Mr. Fred P. Burke
Employees
3,600
Sector
Healthcare
Industry
Medical Care Facilities
Country
United States
Exchange
NYSE
Market Cap (listing currency)
USD 2347M
Currency
USD

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is Guardian Pharmacy Services, Inc. (GRDN) halal to invest in?

The current automated result is More financial data is needed. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is Guardian Pharmacy Services, Inc.'s debt ratio?

Guardian Pharmacy Services, Inc.'s debt ratio is 9.0% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are Guardian Pharmacy Services, Inc.'s key financial metrics?

Guardian Pharmacy Services, Inc. has a market capitalization of USD 2347M in its listing currency, trailing P/E ratio of 35.6, and revenue of $1.4B. The company maintains a gross margin of 21.6% and a net margin of 4.5%. Return on equity stands at 30.4%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.